Epigenetic Regulation of Autophagy by the Methyltransferase EZH2 Through an MTOR-dependent Pathway.
Fu-Zheng Wei,Ziyang Cao,Xi Wang,Hui Wang,Mu-Yan Cai,Tingting Li,Naoko Hattori,Donglai Wang,Yipeng Du,Boyan Song,Lin-Lin Cao,Changchun Shen,Lina Wang,Haiying Wang,Yang,Dan Xie,Fan Wang,Toshikazu Ushijima,Ying Zhao,Wei-Guo Zhu
DOI: https://doi.org/10.1080/15548627.2015.1117734
IF: 13.391
2015-01-01
Autophagy
Abstract:Macroautophagy is an evolutionarily conserved cellular process involved in the clearance of proteins and organelles. Although the autophagy regulation machinery has been widely studied, the key epigenetic control of autophagy process still remains unknown. Here we report that the methyltransferase EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) epigenetically represses several negative regulators of the MTOR (mechanistic target of rapamycin [serine/threonine kinase]) pathway, such as TSC2, RHOA, DEPTOR, FKBP11, RGS16 and GPI. EZH2 was recruited to these genes promoters via MTA2 (metastasis associated 1 family, member 2), a component of the nucleosome remodeling and histone deacetylase (NuRD) complex. MTA2 was identified as a new chromatin binding protein whose association with chromatin facilitated the subsequent recruitment of EZH2 to silenced targeted genes, especially TSC2. Downregulation of TSC2 (tuberous sclerosis 2) by EZH2 elicited MTOR activation, which in turn modulated subsequent MTOR pathway-related events, including inhibition of autophagy. In human colorectal carcinoma (CRC) tissues, the expression of MTA2 and EZH2 correlated negatively with expression of TSC2, which reveals a novel link among epigenetic regulation, the MTOR pathway, autophagy induction, and tumorigenesis.